Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: AMRI | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: AMRI

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI

2Q Revenues: $49.4 million (+8%)

2Q Earnings: $4.6 million (loss of $353,000 in 2Q2006)*

YTD Revenues: $97.7 million (+10%)

YTD Earnings: $7.8 million (earnings were $1.5 million YTD2006)

Comments: Contract revenue in the quarter was $39.9 million, up 4%. Contract revenue from development and small-scale manufacturing was $10.6 million, up 25%, while large-scale manufacturing revenue was down 5% to $19.6 million. Revenue from discovery services in the quarter was $9.7 million, up 6%. YTD development and small-scale manufacturing revenues were $20.9 million, up 21% and YTD large-scale manufacturing revenues were $40.7 million, up 2%.

*2Q2006 earnings included charges of $2.2 million to reduce the carrying value of the company’s former Mount Prospect Research Center.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters